Profiel
Louis J.
Arcudi is Co-President & Secretary at Millendo Therapeutics US, Inc. Formerly, Mr. Arcudi was President, Chief Executive Officer & Director at Millendo Therapeutics, Inc. in 2021.
From 2015 to 2018, served as CFO, Treasurer & Chief Accounting Officer at Idera Pharmaceuticals, Inc. From 2002 to 2007, held the position of Treasurer, VP-Administration & Finance at Peptimmune, Inc. Between 2000 and 2003, was Senior Director-Finance & Administration at Genzyme Molecular Oncology.
In 2003, was Senior Director-Finance Business Planning at Genzyme Corp.
Also worked as Controller at Cognex Corp.
Education includes an undergraduate degree from Southern New Hampshire University in 1982 and an MBA from Bryant University in 1987.
Actieve functies van Louis J. Arcudi
| Bedrijven | Functie | Begin |
|---|---|---|
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | President | - |
Eerdere bekende functies van Louis J. Arcudi
| Bedrijven | Functie | Einde |
|---|---|---|
| MILLENDO THERAPEUTICS | Algemeen Directeur | 25-06-2021 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Financieel Directeur/CFO | 31-10-2018 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Financieel Directeur/CFO | 01-12-2007 |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Financieel Directeur/CFO | 01-01-2003 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Financieel Directeur/CFO | 01-01-2003 |
Opleiding van Louis J. Arcudi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Cognex Corp.
Cognex Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets machine vision computer systems | Electronic Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Southern New Hampshire University
Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Health Technology |
Bryant University
Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















